Hotung's investee company Crystalvue lists on Taipei Exchange
MAINBOARD-LISTED Hotung Investment Holdings' investee company, Crystalvue Medical Corporation, has listed on the Taipei Exchange on Dec 25, the venture capital investment group said on Wednesday.
Crystalvue's initial public offering share price was set at NT$58.80, according to a Taiwan Stock Exchange media statement.
Taiwan-based Crystalvue engages mainly in the research, development, manufacture and sale of ophthalmic diagnostic medical devices.
It is also the sole distributor of a brand of gastrointestinal endoscopic disposable devices.
It has developed its own eye diagnostic products such as the fundus camera and automatic non-contact tonometer.
Shares of Hotung Investment remained unchanged at S$1.74 as at 9.38am.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
DBS customers unable to log into digibank, PayLah! on Thursday
NYSE-parent ICE’s revenue misses as muted IPO markets offset record energy trading
Amazon bets big with CrowdStrike on cybersecurity products
Goldman Sachs scraps EU-era bonus cap for top bankers in UK: source
Thomson Reuters lifts 2024 forecast on first quarter revenue result
US: Wall St opens higher after Fed leaves interest rates alone